[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 28, 2005

Electrocardiographic Effects of a Dietary Supplement Containing Ephedra and Caffeine

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;294(12):1487-1488. doi:10.1001/jama.294.12.1487-a

To the Editor: Controlled studies of the toxicity of over-the-counter drugs are uncommon, so the study by Dr McBride and colleagues1 of a dietary supplement containing ephedra and caffeine (DSEC) was an important addition to the literature. However, some additional data from that study would be helpful.

Dr McBride and colleagues reported that participants taking DSEC had a significantly increased electrocardiographic (ECG) QTc interval, compared with placebo, when it was calculated by either the Bazett or Framingham formulas. Unfortunately, the source article for the Framingham calculation2 quoted an incorrect formula. One of the participants in the DSEC study had a heart rate of 120/min while taking DSEC. A healthy participant with a heart rate of 120/min who had a QTc interval of 380 milliseconds by the correct Framingham formula would have a QTc interval of 429 milliseconds by the Bazett formula and 1073 milliseconds by the incorrect Framingham formula.2 The QTc interval is calculated by formulas that correct the QT interval for changes in RR interval. Therefore, selection of the appropriate QTc correction formula is critical in this study since participants’ average RR intervals were 785.7 milliseconds at baseline, 834.2 milliseconds after placebo, and 849.0 milliseconds after DSEC.

First Page Preview View Large
First page PDF preview
First page PDF preview
×